Format

Send to

Choose Destination
Cell Stem Cell. 2016 Aug 4;19(2):154-157. doi: 10.1016/j.stem.2016.06.007. Epub 2016 Jun 30.

Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.

Author information

1
Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.
2
Department of Cell Biology and Human Anatomy, University of California, Davis, Davis, CA 95616, USA; Institute of Pediatric Regenerative Medicine, Shriners Hospital For Children Northern California, Sacramento, CA 95817, USA. Electronic address: knoepfler@ucdavis.edu.

Abstract

Direct-to-consumer marketing of unapproved stem cell interventions is a well-known phenomenon in countries with lax medical regulations. However, an examination of Internet-based marketing claims revealed widespread promotion of such interventions by businesses based in the United States. Such commercial activity suggests that regulatory agencies must better oversee this marketplace.

PMID:
27374789
DOI:
10.1016/j.stem.2016.06.007
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center